/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mariana Chávez‐MacGregor

The University of Texas MD Anderson Cancer Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

317

Papers

14.0K

Citations

53

h-index

133

i10-index

Mariana Chávez‐MacGregor is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies. The author has an h-index of 53, co-authored 270 publications.

ORCID: 0000-0002-7189-0763

Research Topics

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Global Cancer Incidence and Screening Breast Lesions and Carcinomas

Papers by this author

works

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

2011 · Journal of Clinical Oncology · 450 citations

https://doi.org/10.1200/jco.2010.33.4441

Amal Melhem‐Bertrandt Mariana Chávez‐MacGregor Xiudong Lei Erika N. Brown

Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer

2014 · Journal of Clinical Oncology · 412 citations

https://doi.org/10.1200/jco.2013.53.3935

Meena S. Moran Stuart J. Schnitt Armando E. Giuliano Jay R. Harris

Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ

2016 · Journal of Clinical Oncology · 358 citations

https://doi.org/10.1200/jco.2016.68.3573

Monica Morrow Kimberly J. Van Zee Lawrence J. Solin Nehmat Houssami

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

2019 · Breast Cancer Research · 225 citations

https://doi.org/10.1186/s13058-019-1154-8

Yan Xing Nancy U. Lin Matthew Maurer Huiqin Chen

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

2024 · Journal of Clinical Oncology · 157 citations

https://doi.org/10.1200/jco.23.00137

Dennis J. Slamon Véronique Dièras Hope S. Rugo Nadia Harbeck

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

2024 · The Breast · 155 citations

https://doi.org/10.1016/j.breast.2024.103756

Fátima Cardoso Shani Paluch–Shimon Eva Schumacher-Wulf Leonor Vasconcelos de Matos

Research topics

topics

Breast Cancer Treatment Studies

HER2/EGFR in Cancer Research

Advanced Breast Cancer Therapies

Global Cancer Incidence and Screening

Breast Lesions and Carcinomas

Chat about Author

Papers

Chat

Click to start Chat